Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen JPY Ion Technology is a leading Chinese service provider specializing in contract sterilization and irradiation for the medical device, pharmaceutical, and food sectors. Founded in 1991 and now a subsidiary of CGN Nuclear Technology Development, the company operates advanced facilities utilizing Cobalt-60 gamma rays and electron beam accelerators. Their core business involves the sterilization of single-use medical supplies, pharmaceutical packaging, and laboratory equipment, maintaining rigorous quality standards such as ISO 13485 and ISO 11137. The company plays a vital role in the healthcare supply chain by ensuring the safety and sterility of medical products before they reach clinical use. JPY is recognized for its high-capacity processing capabilities and its integration of advanced nuclear technology into life science applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen JPY Ion Tech.